Re: Effect of Longer-interval Versus Standard Dosing of Zoledronic Acid on Skeletal Events in Patients with Bone Metastases.

View/Open

Accepted version (219.2Kb)

Publication Date

2018-02

ICR Author

Author

Parker, C

Type

Journal Article

Metadata

Show full item record

URL

https://repository.icr.ac.uk/handle/internal/1022

Collections

Other ICR Research

Licenseref URL

http://www.rioxx.net/licenses/under-embargo-all-rights-reserved

Version of record

10.1016/j.eururo.2017.11.007

Subject

Bone Density Conservation Agents

Bone Neoplasms

Diphosphonates

Humans

Imidazoles

Zoledronic Acid

Language

eng

Date accepted

2017-11-09

License start date

2018-02

Citation

Eur Urol, 2018, 73 (2), pp. 304 - ?